Contamination During Removal of Two Different Personal Protective Systems
Highly communicable and virulent diseases, the ongoing threat of emerging infectious diseases, and the prospect of bio-terrorism have become part of the new reality for health care workers. SARS transmission has occurred despite the use of droplet, contact, and airborne precautions. Potential explanations for some of the episodes of “through-precautions” transmission include the possibility of contamination during removal of protective clothing.
The recommended protective systems (PPS) for aerosol generating procedures set out by the US Center for Disease Control and Prevention (CDC) and the Ontario Ministry of Health and Long Term Care (MOHLTC) differ.
The failure of a PPS may be associated with significant consequences in terms of the morbidity and mortality of front-line health care workers. The purpose of this study is to determine if a difference exists between the rate of self-contamination due to deficiencies in contact precautions for individuals wearing either the CDC or MOHLTC recommended PPS.
Study participants will don one of the two recommended PPS, be “contaminated” with an indicator that becomes visible under ultraviolet light, and then assessed for contamination of clothing layers and skin after removal of the PPS. They will then repeat the procedure using the other PPS.
|Severe Acute Respiratory Syndrome||Procedure: Powered Air purifying respirator|
|Study Design:||Allocation: Randomized
Intervention Model: Crossover Assignment
Primary Purpose: Educational/Counseling/Training
|Official Title:||Contamination During Removal of Two Different Personal Protective Systems When Working Under Conditions Requiring Enhanced Respiratory and Contact Precautions|
- The primary endpoint of this study is the presence of any detected
- base clothing layer, skin, or hair contamination.
- The secondary endpoints: 1) contamination episodes of any layer, and 2) protective
- system donning and removal procedure violations
|Study Start Date:||January 2005|
|Estimated Study Completion Date:||May 2005|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00150475
|Kingston General Hospital|
|Kingston, Ontario, Canada, K7L 2V7|
|Principal Investigator:||Jorge E. Zamora, MD||Queen's University|